Document is current

Article History

Received: 23 November 2023

Accepted: 23 December 2024

First Online: 20 January 2025

Declarations

:

: Approval for this study was waived by WIRB-Copernicus Group Institutional Review Board who waived the approval due to the study only including interactions involving survey procedures, having adequate provisions to protect the privacy of subjects and maintain confidentiality of data, following review under the Common Rule and based on Code of Federal Regulations Title 45, Part 46, Subpart A, Sect. 46.104d, Category 2 criteria. Informed consent was taken from each study participant before initiating the survey. The study was conducted in compliance with the Declaration of Helsinki and its amendments.

: Not applicable.

: Amy Perrin Ross has received consulting fees from Alexion, BMS, EMD Serono, Horizon, Novartis, Roche, Sanofi, and TG Therapeutics. Jacqueline Nicholas has received research grants from Biogen, Genentech, Novartis, PCORI, and the University of Buffalo; has received consulting fees from EMD Serono, Genentech, Greenwich Biosciences, Novartis, Sanofi, and TG Therapeutics; and has received speaking honoraria from BMS, EMD Serono, Horizon, and TG Therapeutics. Ming-Hui Tai and Stephen Yeung are employees of Novartis Pharmaceuticals Corporation. Nazneen Fatima Shaikh, Helen Chen, Mariana Fernandes, Aaron Cortright, and Kevin Hawkins are employees of Real World Solutions, IQVIA.